ORPHAZYME Trademark

Trademark Overview


On Tuesday, December 1, 2015, a trademark application was filed for ORPHAZYME with the United States Patent and Trademark Office. The USPTO has given the ORPHAZYME trademark a serial number of 79180936. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, August 25, 2023. This trademark is owned by Orphazyme ApS. The ORPHAZYME trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical and medical preparations for the treatment of rare and genetic diseases, for the treatment of diseases involving protein misfolding, for the treatment of diseases involving lysosomal pathology, for the treatment of disorders of the central nervous system, for the treatment of neurodegenerative diseases, for the treatment of neuropsychiatric disorders, for the treatment of movement disorders, for the treatment of parkinsonism and Parkinson's disease, for the treatment of Amyotrophic lateral sclerosis (ALS), motor neuron disease (MND) and Lysosomal storage diseases (LSD) and for the treatment of Niemann-Pick disease type C, for the treatment of diseases associated with dysregulation of cholesterol homeostasis, cholesterol trafficking, cholesterol metabolism and cholesterol biosynthesis and for the treatment of atherosclerosis; chemical-pharmaceutical preparations for the treatment of rare and genetic diseases, for the treatment of diseases involving protein misfolding, for...

Chemicals used in industry and in science; proteins for use in science and in manufacture; biochemicals, namely, polypeptides for scientific, research and commercial use; with the exclusion of chemicals used in the food industry and animal food industry and ingredients for foodstuffs for animals

Industrial analysis and research services; basic research and clinical research, hereunder for medicine and vaccine development; all the aforementioned services with the exclusion of services relating to the veterinary sector
orphazyme

General Information


Serial Number79180936
Word MarkORPHAZYME
Filing DateTuesday, December 1, 2015
Status709 - CANCELLED - SECTION 71
Status DateFriday, August 25, 2023
Registration Number5139414
Registration DateTuesday, February 14, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 29, 2016

Trademark Statements


Goods and ServicesPharmaceutical and medical preparations for the treatment of rare and genetic diseases, for the treatment of diseases involving protein misfolding, for the treatment of diseases involving lysosomal pathology, for the treatment of disorders of the central nervous system, for the treatment of neurodegenerative diseases, for the treatment of neuropsychiatric disorders, for the treatment of movement disorders, for the treatment of parkinsonism and Parkinson's disease, for the treatment of Amyotrophic lateral sclerosis (ALS), motor neuron disease (MND) and Lysosomal storage diseases (LSD) and for the treatment of Niemann-Pick disease type C, for the treatment of diseases associated with dysregulation of cholesterol homeostasis, cholesterol trafficking, cholesterol metabolism and cholesterol biosynthesis and for the treatment of atherosclerosis; chemical-pharmaceutical preparations for the treatment of rare and genetic diseases, for the treatment of diseases involving protein misfolding, for the treatment of diseases involving lysosomal pathology, for the treatment of disorders of the central nervous system, for the treatment of neurodegenerative diseases, for the treatment of neuropsychiatric disorders, for the treatment of movement disorders, for the treatment of parkinsonism and Parkinson's disease, for the treatment of Amyotrophic lateral sclerosis (ALS), motor neuron disease (MND) and Lysosomal storage diseases (LSD) and for the treatment of Niemann-Pick disease type C, for the treatment of diseases associated with dysregulation of cholesterol homeostasis, cholesterol trafficking, cholesterol metabolism and cholesterol biosynthesis and for the treatment of atherosclerosis; diagnostic preparations for medical purposes; reagents for medical purposes and for research; preparations for analysis for medical and research purposes for the treatment of rare and genetic diseases, for the treatment of diseases involving protein misfolding, for the treatment of diseases involving lysosomal pathology, for the treatment of disorders of the central nervous system, for the treatment of neurodegenerative diseases, for the treatment of neuropsychiatric disorders, for the treatment of movement disorders, for the treatment of parkinsonism and Parkinson's disease, for the treatment of Amyotrophic lateral sclerosis (ALS), motor neuron disease (MND) and Lysosomal storage diseases (LSD) and for the treatment of Niemann-Pick disease type C, for the treatment of diseases associated with dysregulation of cholesterol homeostasis, cholesterol trafficking, cholesterol metabolism and cholesterol biosynthesis and for the treatment of atherosclerosis; all of the aforementioned with the exclusion of veterinary preparations and ingredients, supplements for food, and medicated foodstuffs for animals
Goods and ServicesChemicals used in industry and in science; proteins for use in science and in manufacture; biochemicals, namely, polypeptides for scientific, research and commercial use; with the exclusion of chemicals used in the food industry and animal food industry and ingredients for foodstuffs for animals
Goods and ServicesIndustrial analysis and research services; basic research and clinical research, hereunder for medicine and vaccine development; all the aforementioned services with the exclusion of services relating to the veterinary sector

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, August 25, 2023
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, August 25, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, August 25, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOrphazyme A/S
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressDK

Party NameOrphazyme ApS
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressDK-2200 København N
DK

Party NameOrphazyme ApS
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDK-2200 København N
DK

Trademark Events


Event DateEvent Description
Thursday, January 21, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB
Thursday, January 28, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 2, 2016APPLICATION FILING RECEIPT MAILED
Monday, March 21, 2016ASSIGNED TO EXAMINER
Friday, March 25, 2016NON-FINAL ACTION WRITTEN
Friday, March 25, 2016NON-FINAL ACTION WRITTEN
Saturday, March 26, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, March 28, 2016REFUSAL PROCESSED BY MPU
Monday, March 28, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, May 13, 2016REFUSAL PROCESSED BY IB
Monday, September 26, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, October 2, 2016ASSIGNED TO LIE
Wednesday, October 5, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 5, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, October 22, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, November 9, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 29, 2016PUBLISHED FOR OPPOSITION
Tuesday, November 29, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, December 22, 2016NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, February 14, 2017REGISTERED-PRINCIPAL REGISTER
Thursday, March 2, 2017NEW REPRESENTATIVE AT IB RECEIVED
Sunday, May 14, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, June 1, 2017FINAL DISPOSITION NOTICE SENT TO IB
Friday, June 23, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, August 31, 2017NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, October 18, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 1, 2017FINAL DISPOSITION PROCESSED
Friday, September 7, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, January 25, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, January 25, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 5, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, May 5, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 5, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 5, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, May 5, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 5, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, June 8, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 8, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 8, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, June 8, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, June 8, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 14, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Sunday, July 10, 2022NEW REPRESENTATIVE AT IB RECEIVED
Thursday, April 25, 2024TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Monday, May 6, 2024INVALIDATION PROCESSED
Monday, May 6, 2024TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Monday, May 27, 2024TOTAL INVALIDATION PROCESSED BY THE IB
Friday, August 25, 2023CANCELLED SECTION 71
Friday, March 30, 2018CHANGE OF NAME/ADDRESS REC'D FROM IB
Saturday, June 12, 2021NEW REPRESENTATIVE AT IB RECEIVED